Identifying and developing novel therapeutic approaches for heart disease

肥胖、糖尿病和人口老龄化的增加增加了心脏病和并发症的风险，包括心力衰竭（HF）、心房颤动（AF）和糖尿病性心脏病。临床需要1)改进心衰、房颤和糖尿病性心脏病患者的治疗方法，以及2)更有效地识别心脏病风险人群的生物标志物，以预防临床事件。我的研究项目旨在开发新的疗法和识别新的生物标志物。

Increasing rates of obesity, diabetes, and an ageing population increase the risk of heart disease & complications including heart failure (HF), atrial fibrillation (AF), and diabetic heart disease. There is a clinical need for i) improved therapies for patients with HF, AF, and diabetic heart, and ii) biomarkers which more effectively recognise people at risk of heart disease, to prevent clinical events. My research program is designed to develop novel therapies and identify new biomarkers.